ROYCE & ASSOCIATES LP - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$213,000
+71.8%
58,0610.0%0.00%
+100.0%
Q3 2020$124,000
+19.2%
58,0610.0%0.00%0.0%
Q2 2020$104,000
+35.1%
58,0610.0%0.00%0.0%
Q1 2020$77,000
-27.4%
58,0610.0%0.00%0.0%
Q4 2019$106,000
-36.9%
58,0610.0%0.00%
-50.0%
Q3 2019$168,000
+8.4%
58,0610.0%0.00%
+100.0%
Q2 2019$155,000
+4.7%
58,0610.0%0.00%0.0%
Q1 2019$148,000
-8.1%
58,0610.0%0.00%0.0%
Q4 2018$161,000
-68.9%
58,0610.0%0.00%
-75.0%
Q3 2018$517,00058,0610.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$68,0000.23%
Virtu Financial LLC 325,330$390,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 141,000$169,0000.02%
Clear Creek Financial Management, LLC 49,696$60,0000.01%
Palo Alto Investors LP 77,044$92,0000.01%
ACADIAN ASSET MANAGEMENT LLC 738,620$886,0000.00%
MARSHALL WACE, LLP 477,449$573,0000.00%
WADE G W & INC 35,000$42,0000.00%
TWO SIGMA ADVISERS, LP 599,471$719,0000.00%
BRYN MAWR TRUST Co 33,892$41,0000.00%
View complete list of IDERA PHARMACEUTICALS INC shareholders